Nanoparticle and targeted systems for cancer therapy

Area of Science:

• Oncology
• Nanomedicine
• Drug Delivery Systems

Background:

• Traditional cancer treatments often lack specificity, leading to systemic side effects.
• Developing targeted therapies is crucial for improving treatment efficacy and patient outcomes.
• Recent advancements focus on novel delivery mechanisms to enhance anti-cancer agent concentration at the tumor site.

Purpose of the Study:

• To review recent advancements in targeted cancer treatment strategies.
• To explore innovative methods for delivering anti-cancer agents.
• To summarize current research on enhancing drug specificity and efficacy.

Main Methods:

• Review of literature on targeted cancer therapy and drug delivery.
• Analysis of strategies including reticuloendothelial system avoidance, enhanced permeability and retention (EPR) effect, and tumor-specific targeting.
• Examination of antibody-targeted therapies, anti-angiogenesis strategies, and nanoparticle-based delivery systems (degradable and non-degradable polymers).

Main Results:

• Targeted delivery can be achieved by evading the reticuloendothelial system.
• The enhanced permeability and retention (EPR) effect aids in passive tumor targeting.
• Active targeting strategies include antibody-drug conjugates and anti-angiogenic therapies.
• Nanoparticle-based drug delivery offers versatile platforms for targeted cancer treatment.

Conclusions:

• Targeted cancer therapies show significant promise for improving treatment outcomes.
• Diverse strategies, including nanoparticle delivery and antibody targeting, are advancing cancer treatment.
• Further research into these targeted approaches is essential for clinical translation and patient benefit.